CompanyDeals

Frontage Laboratories Expands European Footprint with Acquisition of Accelera’s DMPK Businesses

CompanyDrug

AstraZeneca and Sanofi’s RSV Prevention Drug Beyfortus Approved by China’s NMPA

CompanyDeals

China Medical System Expands into Southeast Asia with Singapore Manufacturing Plant Lease

CompanyDrug

Ascletis Pharma’s ASC41 Shows Promising Results in Phase II NASH Study

CompanyDrug

Shanghai Junshi Biosciences’ Toripalimab Gains NMPA Approval for NSCLC Perioperative Treatment

CompanyDrug

Roche’s Phesgo and Faricimab Receive NMPA Approvals for Breast Cancer and nAM

CompanyDeals

WuXi XDC and IntoCell Enter MOU to Advance Toxin Linker Technology and CRDMO Services

CompanyDrug

BeiGene’s Tislelizumab Secures 12th Indication Approval in China for HCC First-Line Treatment

CompanyDrug

BMS’ Augtyro Receives EMA Review for Advanced Lung Cancer and Solid Tumors Treatments

CompanyDeals

Allorion Therapeutics Strikes Deal with AstraZeneca for EGFR L858R Inhibitor Development and Commercialization

CompanyDeals

Orient Gene Biotech to Acquire Hangzhou Laihe Biotech, Expanding POCT and AI in Healthcare

CompanyDeals

Shanghai Teogen Life Technology and China National Medical Device Form Strategic Partnership